Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Non-Current Debt (2016 - 2022)

Alaunos Therapeutics (TCRT) has disclosed Non-Current Debt for 3 consecutive years, with $4.5 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Non-Current Debt changed N/A year-over-year to $4.5 million, compared with a TTM value of $4.5 million through Jun 2022, changed N/A, and an annual FY2021 reading of $16.2 million, changed N/A over the prior year.
  • Non-Current Debt was $4.5 million for Q2 2022 at Alaunos Therapeutics, down from $10.3 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $16.2 million in Q4 2021 and bottomed at $4.5 million in Q2 2022.